Ganglioside GM3 exerts opposite effects on motility via epidermal growth factor receptor and hepatocyte growth factor receptor-mediated migration signaling

Li,Ying; Huang,Xiaohua; Wang,Congcong; Li,Yuzhong; Luan,Mingchun; Ma,Keli

doi:10.3892/mmr.2014.3087

Ganglioside GM3 exerts opposite effects on motility via epidermal growth factor receptor and hepatocyte growth factor receptor-mediated migration signaling

Authors:
- Ying Li
- Xiaohua Huang
- Congcong Wang
- Yuzhong Li
- Mingchun Luan
- Keli Ma
View Affiliations

Affiliations: Department of Clinical Laboratory, Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116023, P.R. China, Department of Biochemistry and Molecular Biology, Dalian Medical University, Dalian, Liaoning 116044, P.R. China, Department of Microbiology Laboratory, Dalian Center for Disease and Prevention, Dalian, Liaoning 116021, P.R. China
Published online on: December 12, 2014 https://doi.org/10.3892/mmr.2014.3087
Pages: 2959-2966

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The ganglioside GM3 exerts its different effects via various growth factor receptors. The present study investigated and comparatively analyzed the opposing effects exerted by GM3 on the migration of mouse hepatocellular carcinoma Hepa1‑6 cells via epidermal growth factor receptor (EGFR) and hepatocyte growth factor receptor (HGFR/cMet). The results demonstrated that GM3 inhibited EGF‑stimulated motility, but promoted HGF‑stimulated motility of the Hepa1‑6 cells via phosphatidylinositol 3‑kinase/Akt‑mediated migration signaling. It is well established that the main cytokines modulating cell proliferation, invasion and metastasis are different in different types of tumor. This difference may, at least in part, explain why GM3 exerted its actions in a tumor‑type specific manner.

View Figures

View References

1	Huwiler A, Kolter T, Pfeilschifter J and Sandhoff K: Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim Biophys Acta. 1485:63–99. 2000. View Article : Google Scholar : PubMed/NCBI
2	Toledo MS, Suzuki E, Handa K and Hakomori S: Cell growth regulation through GM3-enriched microdomain (glycosynapse) in human lung embryonal fibroblast WI38 and its oncogenic transformant VA13. J Biol Chem. 279:34655–34664. 2004. View Article : Google Scholar : PubMed/NCBI
3	Hakomori S: Glycosphingolipids in cellular interaction, differentiation and oncogenesis. Annu Rev Biochem. 50:733–764. 1981. View Article : Google Scholar
4	Regina-Todeschini A and Hakomori SI: Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. Biochim Biophys Acta. 1780:421–433. 2008. View Article : Google Scholar
5	Hakomori SI: Glycosynaptic microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and motility. FEBS Lett. 584:1901–1906. 2010. View Article : Google Scholar :
6	Van Echten G and Sandhoff K: Ganglioside metabolism. Enzymology, topology, and regulation. J Biol Chem. 268:5341–5344. 1993.PubMed/NCBI
7	Iwabuchi K, Yamamura S, Prinetti A, Handa K and Hakomori S: GM3- enriched microdomain involvedin cell adhesion and signal transduction through carbohydrate-carbohydrate interaction in mouse melanoma B16 cells. J Biol Chem. 273:9130–9138. 1998. View Article : Google Scholar : PubMed/NCBI
8	Kojima N and Hakomori S: Cell adhesion, spreading, and motility of GM3-expressing cells based on glycolipid-glycolipid interaction. J Biol Chem. 266:17552–17558. 1991.PubMed/NCBI
9	Hakomori S: Tumor malignancy defined by aberrant glycosylation and sphingo (glyco) lipid metabolism. Cancer Res. 56:5309–5318. 1996.PubMed/NCBI
10	Birklé S, Zeng G, Gao L, Yu RK and Aubry J: Role of tumor-associated gangliosides in cancer progression. Biochimie. 85:455–463. 2003. View Article : Google Scholar : PubMed/NCBI
11	Fujimoto Y, Izumoto S, Suzuki T, et al: Ganglioside GM3 inhibits proliferation and invasion of glioma. Neurooncol. 71:99–106. 2005. View Article : Google Scholar
12	Kawamura S, Ohyama C, Watanabe R, et al: Glycolipid composition in bladder tumor: a crucial role of GM3 ganglioside in tumor invasion. Int J Cancer. 94:343–347. 2001. View Article : Google Scholar : PubMed/NCBI
13	Wang XQ, Sun P and Paller AS: Ganglioside GM3 blocks the activation of epidermal growth factor receptor induced by integrin at specific tyrosine sites. J Biol Chem. 278:48770–48778. 2003. View Article : Google Scholar : PubMed/NCBI
14	Wang XQ, Sun P, Go L, et al: Ganglioside GM3 promotes carcinoma cell proliferation via urokinase plasminogen activator-induced extracellular signal-regulated kinase-independent p70S6 kinase signaling. J Invest Dermatol. 6:2687–2696. 2006. View Article : Google Scholar
15	Mitsuzuka K, Handa K, Satoh M, Arai Y and Hakomori S: A specific microdomain (“glycosynapse 3”) controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9. J Biol Chem. 280:35545–35553. 2005. View Article : Google Scholar : PubMed/NCBI
16	Saha S and Mohanty KC: Enhancement of metastatic potential of mouse B16-melanoma cells to lung after treatment with gangliosides of B-16-melanoma cells of higher metastatic potential to lung. Indian J Exp Biol. 41:1253–1258. 2003.
17	Gu Y, Zhang J, Mi W, et al: Silencing of GM3 synthase suppresses lung metastasis of murine breast cancer cells. Breast Cancer Res. 10:1–12. 2008. View Article : Google Scholar
18	Ladisch S and Gillard B: A solvent partition method for microscale ganglioside purification. Anal Biochem. 146:220–231. 1985. View Article : Google Scholar : PubMed/NCBI
19	Biscardi JS, Maa MC, Tice DA, et al: c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J Biol Chem. 274:8335–8343. 1999. View Article : Google Scholar : PubMed/NCBI
20	Bremer EG and Hakomori S: GM3 ganglioside induces hamster fibroblast growth factor inhibition in chemically defined medium: ganglioside may regulate growth factor receptor function. Biochem Biophys Res Commun. 106:711–728. 1982. View Article : Google Scholar : PubMed/NCBI
21	Rebbaa A, Hurh J, Yamamoto K, Kersey D and Bremer EG: Ganglioside GM3 inhibition of EGF receptor mediated signal transduction. Glycobiology. 6:399–406. 1996. View Article : Google Scholar : PubMed/NCBI
22	Meuillet E, Cremel G, Dreyfus H and Hicks D: Differential modulation of basic fibroblast and epidermal growth factor receptor activation by ganglioside GM3 in cultured retinal Muller glia. Glia. 17:206–216. 1996. View Article : Google Scholar : PubMed/NCBI
23	Yates AJ, Saqr HE and Van Brocklyn J: Ganglioside modulation of PDGF receptor. A model for ganglioside functions. J Neurooncology. 24:65–73. 1995. View Article : Google Scholar
24	Mukherjee P, Faber AC, Shelton LM, et al: Thematic review series: sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a. J Lipid Res. 49:929–938. 2008. View Article : Google Scholar : PubMed/NCBI
25	Chung TW, Kim SJ, Choi HJ, et al: Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2. Glycobiology. 19:229–239. 2009. View Article : Google Scholar
26	Kawakami Y, Kawakami K, Steelant WF, et al: Tetraspanin CD9 is a “proteolipid,” and its interaction with alpha 3 integrin in microdomain is promoted by GM3 ganglioside, leading to inhibition of laminin-5-dependent cell motility. J Biol Chem. 277:34349–34358. 2002. View Article : Google Scholar : PubMed/NCBI
27	Ono M, Handa K, Sonnino S, et al: GM3 ganglioside inhibits CD9-facilitated haptotactic cell motility: coexpression of GM3 and CD9 is essential in the downregulation of tumor cell motility and malignancy. Biochemistry. 40:6414–6421. 2001. View Article : Google Scholar : PubMed/NCBI
28	Todeschini AR, Dos Santos JN, Handa K and Hakomori SI: Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway. Proc Natl Acad Sci USA. 105:1925–1930. 2008. View Article : Google Scholar : PubMed/NCBI
29	Suárez Pestana E, Greiser U, Sánchez B, et al: Growth inhibition of human lung adenocarcinoma cells by antibodies against epidermal growth factor receptor and by ganglioside GM3: involvement of receptor-directed protein tyrosine phosphatase(s). Br J Cancer. 75:213–220. 1997. View Article : Google Scholar : PubMed/NCBI
30	Suárez Pestana E, Tenev T, Gross S, et al: The transmembrane protein tyrosine phosphatase RPTP sigma modulates signaling of the epidermal growth factor receptor in A431 cells. Oncogene. 18:4069–4079. 1999. View Article : Google Scholar
31	Bassi R, Viani P, Giussani P, Riboni L and Tettamanti G: GM3ganglioside inhibits endothelin-1-mediated signal transduction in C6 glioma cells. FEBS Lett. 507:101–104. 2001. View Article : Google Scholar : PubMed/NCBI